Epigenetic modification of DRG neuronal gene expression subsequent to nerve injury: Etiological contribution to complex regional pain syndromes (Part I)

Medical Science Monitor

Volumn 20, Issue , 2014, Pages 1067-1077

  Wang, Fuzhou ^a,b   Stefano, George B ^c   Kream, Richard M ^c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Division of Neuroscience Bonoi Academy of Science and Education   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Chronic pain; Complex regional pain syndromes; Epigenomics; Ganglia, spinal; Peripheral nerve injuries

Indexed keywords

CYTOKINE; ION CHANNEL; NEUROTRANSMITTER; PROSTAGLANDIN; AUTACOID;

ACTION POTENTIAL; COMPLEX REGIONAL PAIN SYNDROME; DOPAMINERGIC TRANSMISSION; EPIGENETICS; GENE EXPRESSION; HUMAN; HYPERSENSITIVITY; INFLAMMATION; NERVE EXCITABILITY; NERVE INJURY; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; GENETIC EPIGENESIS; GENETICS; METABOLISM; NERVE CELL; NERVOUS TISSUE; PATHOLOGY; SPINAL GANGLION;

ANIMALS; COMPLEX REGIONAL PAIN SYNDROMES; EPIGENESIS, GENETIC; GANGLIA, SPINAL; HUMANS; INFLAMMATION MEDIATORS; NERVE TISSUE; NEURONS;

EID: 84903165086     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.890702     Document Type: Review

References (98)

1. Stanton-Hicks M, Janig W, Hassenbusch S et al: Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain, 1995; 63: 127-33
2. Maihöfner C, Seifert F, Markovic K: Complex regional pain syndromes: new pathophysiological concepts and therapies. Eur J Neurol, 2010; 17: 649-60
3. Parkitny L, McAuley JH, Di Pietro F et al: Inflammation in complex regional pain syndrome: a systematic review and meta-analysis. Neurology, 2013; 80: 106-17
4. Campero M, Bostock H, Baumann TK, Ochoa JL: A search for activation of C nociceptors by sympathetic fibers in complex regional pain syndrome. Clin Neurophysiol, 2010; 121: 1072-79
5. Ochoa JL, Verdugo RJ: Neuropathic pain syndrome displayed by malingerers. J Neuropsychiatry Clin Neurosci, 2010; 22: 278-86
6. Sapunar D, Kostic S, Banozic A, Puljak L: Dorsal root ganglion-a potential new therapeutic target for neuropathic pain. J Pain Res, 2012; 5: 31-38
7. Barreveld A, Witte J, Chahal H et al: Preventive analgesia by local anesthetics: the reduction of postoperative pain by peripheral nerve blocks and intravenous drugs. Anesth Analg, 2013; 116: 1141-61
8. Mogil JS: Animal models of pain: progress and challenges. Nat Rev Neurosci, 2009; 10: 283-94
9. st ed. Transworld Research Network, 2013; 1-18
10. Teperino R, Lempradl A, Pospisilik JA: Bridging epigenomics and complex disease: the basics. Cell Mol Life Sci, 2013; 70: 1609-21
11. Noaman HH: Surgical treatment of peripheral nerve injury. In: Rayegani SM (ed.)m Basic Principles of Peripheral Nerve Disorders. InTech, 2012; 93-132
12. Campbell JN: Nerve lesions and the generation of pain. Muscle Nerve, 2001; 24(10): 1261-73
13. Oaklander AL, Fields HL: Is reflex sympathetic dystrophy/complex regional pain syndrome type I a small-fiber neuropathy? Ann Neurol, 2009; 65: 629-38
14. Wang W, Gu J, Li YQ, Tao YX: Are voltage-gated sodium channels on the dorsal root ganglion involved in the development of neuropathic pain? Mol Pain, 2011; 7: 16
15. Hao J, Padilla F, Dandonneau M et al: Kv1.1 channels act as mechanical brake in the senses of touch and pain. Neuron, 2013; 77: 899-914
16. Mi Y, Zhang X, Zhang F et al: The role of potassium channel activation in celecoxib-induced analgesic action. PLoS One, 2013; 8: e54797
17. Tsantoulas C, Zhu L, Shaifta Y et al: Sensory neuron downregulation of the Kv9.1 potassium channel subunit mediates neuropathic pain following nerve injury. J Neurosci, 2012; 32: 17502-13
18. Todorovic SM, Jevtovic-Todorovic V: T-type voltage-gated calcium channels as targets for the development of novel pain therapies. Br J Pharmacol, 2011; 163: 484-95
19. Price TJ, Cervero F, de Koninck Y: Role of cation-chloride-cotransporters (CCC) in pain and hyperalgesia. Curr Top Med Chem, 2005; 5: 547-55
20. Kim J, Kim SJ, Lee H, Chang JW: Effective neuropathic pain relief through sciatic nerve administration of GAD65-expressing rAAV2. Biochem Biophys Res Commun, 2009; 388: 73-78
21. Malet M, Vieytes CA, Lundgren KH et al: Transcript expression of vesicular glutamate transporters in lumbar dorsal root ganglia and the spinal cord of mice-Effects of peripheral axotomy or hindpaw inflammation. Neuroscience, 2013; 248C: 95-111
22. Moechars D, Weston MC, Leo S et al: Vesicular glutamate transporter VGLUT2 expression levels control quantal size and neuropathic pain. J Neurosci, 2006; 26: 12055-66
23. Liu H, Mantyh PW, Basbaum AI: NMDA-receptor regulation of substance P release from primary afferent nociceptors. Nature, 1997; 386: 721-24
24. Ault B, Hildebrand LM: Activation of nociceptive reflexes by peripheral kainate receptors. J Pharmacol Exp Ther, 1993; 265: 927-32
25. Lee CJ, Bardoni R, Tong CK et al: Functional expression of AMPA receptors on central terminals of rat dorsal root ganglion neurons and presynaptic inhibition of glutamate release. Neuron, 2002; 35: 135-46
26. Obata K, Yamanaka H, Fukuoka T et al: Contribution of injured and uninjured dorsal root ganglion neurons to pain behavior and the changes in gene expression following chronic constriction injury of the sciatic nerve in rats. Pain, 2003; 101: 65-77
27. Xiao HS, Huang QH, Zhang FX et al: Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain. Proc Natl Acad Sci USA, 2002; 99: 8360-65
28. Engle MP, Merrill MA, Marquez De Prado B, Hammond DL: Spinal nerve ligation decreases g-aminobutyric acidB receptors on specific populations of immunohistochemically identified neurons in L5 dorsal root ganglion of the rat. J Comp Neurol, 2012; 520: 1663-77
29. Chattopadhyay M, Mata M, Fink DJ: Vector-mediated release of GABA attenuates pain-related behaviors and reduces Na(V)1.7 in DRG neurons. Eur J Pain, 2011; 15: 913-20
30. Laínez S, Valente P, Ontoria-Oviedo I et al: GABAA receptor associated protein (GABARAP) modulates TRPV1 expression and channel function and desensitization. FASEB J, 2010; 24: 1958-70
31. Kim J, Kim SJ, Lee H, Chang JW: Effective neuropathic pain relief through sciatic nerve administration of GAD65-expressing rAAV2. Biochem Biophys Res Commun, 2009; 388: 73-78
32. Dal Bo G, Bérubé-Carrière N, Mendez JA et al: Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion. Neuroscience, 2008; 156: 59-70
33. Austin PJ, Beyer K, Bembrick AL, Keay KA: Peripheral nerve injury differentially regulates dopaminergic pathways in the nucleus accumbens of rats with either, pain alone' or, pain and disability'. Neuroscience, 2010; 171: 329-43
34. Dang YH, Zhao Y, Xing B et al: The role of dopamine receptors in ventrolateral orbital cortex-evoked anti-nociception in a rat model of neuropathic pain. Neuroscience, 2010; 169: 1872-80
35. Ansah OB, Leite-Almeida H, Wei H, Pertovaara A: Striatal dopamine D2 receptors attenuate neuropathic hypersensitivity in the rat. Exp Neurol, 2007; 205: 536-46
36. Narita M, Suzuki M, Imai S et al: Molecular mechanism of changes in the morphine-induced pharmacological actions under chronic pain-like state: suppression of dopaminergic transmission in the brain. Life Sci, 2004; 74: 2655-73
37. Decosterd I, Woolf CJ: Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain, 2000; 87: 149-58
38. Nackley AG, Tan KS, Fecho K et al: Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2-and beta3-adrenergic receptors. Pain, 2007; 128: 199-208
39. Tanimoto K, Takebayashi T, Kobayashi T et al: Does norepinephrine influence pain behavior mediated by dorsal root ganglia?: a pilot study. Clin Orthop Relat Res, 2011; 469: 2568-76
40. Gu M, Miyoshi K, Dubner R et al: Spinal 5-HT(3) receptor activation induces behavioral hypersensitivity via a neuronal-glial-neuronal signaling cascade. J Neurosci, 2011; 31: 12823-36
41. Xie DJ, Uta D, Feng PY et al: Identification of 5-HT receptor subtypes enhancing inhibitory transmission in the rat spinal dorsal horn in vitro. Mol Pain, 2012; 8: 58
42. Nakamoto H, Soeda Y, Seki T et al: Possible involvement of descending serotonergic systems in antinociception by centrally administered elcatonin in mice. Biol Pharm Bull, 1999; 22: 691-97
43. Cardenas CG, Mar LP, Vysokanov AV et al: Serotonergic modulation of hyperpolarization-activated current in acutely isolated rat dorsal root ganglion neurons. J Physiol, 1999; 518: 507-23
44. Saydoff JA, Rittenhouse PA, van de Kar LD, Brownfield MS: Enhanced serotonergic transmission stimulates oxytocin secretion in conscious male rats. J Pharmacol Exp Ther, 1991; 257: 95-99
45. Vadivelu N, Mitra S, Hines RL: Peripheral opioid receptor agonists for analgesia: a comprehensive review. J Opioid Manag, 2011; 7: 55-68
46. Ma J, Pan ZZ: Contribution of brainstem GABA(A) synaptic transmission to morphine analgesic tolerance. Pain, 2006; 122: 163-73
47. Duman EN, Kesim M, Kadioglu M et al: Possible involvement of opioidergic and serotonergic mechanisms in antinociceptive effect of paroxetine in acute pain. J Pharmacol Sci, 2004; 94: 161-65
48. Erthal V, da Silva MD, Cidral-Filho FJ et al: ST36 laser acupuncture reduces pain-related behavior in rats: involvement of the opioidergic and serotonergic systems. Lasers Med Sci, 2013; 28: 1345-51
49. Mazzardo-Martins L, Martins DF, Marcon R et al: High-intensity extended swimming exercise reduces pain-related behavior in mice: involvement of endogenous opioids and the serotonergic system. J Pain, 2010; 11: 1384-93
50. Höcker J, Böhm R, Meybohm P et al: Interaction of morphine but not fentanyl with cerebral alpha2-adrenoceptors in alpha2-adrenoceptor knockout mice. J Pharm Pharmacol, 2009; 61: 901-10
51. Tamagaki S, Suzuki T, Hagihira S et al: Systemic daily morphine enhances the analgesic effect of intrathecal dexmedetomidine via up-regulation of alpha 2 adrenergic receptor subtypes A, B and C in dorsal root ganglion and dorsal horn. J Pharm Pharmacol, 2010; 62: 1760-67
52. Yalcin I, Tessier LH, Petit-Demoulière N et al: Chronic treatment with agonists of beta(2)-adrenergic receptors in neuropathic pain. Exp Neurol, 2010; 221: 115-21
53. Favaroni Mendes LA, Menescal-de-Oliveira L: Role of cholinergic, opioidergic and GABAergic neurotransmission of the dorsal hippocampus in the modulation of nociception in guinea pigs. Life Sci, 2008; 83: 644-50
54. Leite-Panissi CR, Brentegani MR, Menescal-de-Oliveira L: Cholinergicopioidergic interaction in the central amygdala induces antinociception in the guinea pig. Braz J Med Biol Res, 2004; 37: 1571-79
55. Velasco-Xolalpa ME, Barragán-Iglesias P, Roa-Coria JE et al: Role of hydrogen sulfide in the pain processing of non-diabetic and diabetic rats. Neuroscience, 2013; 250: 786-97
56. Feng X, Zhou YL, Meng X et al: Hydrogen sulfide increases excitability through suppression of sustained potassium channel currents of rat trigeminal ganglion neurons. Mol Pain, 2013; 9: 4
57. Okubo K, Matsumura M, Kawaishi Y et al: Hydrogen sulfide-induced mechanical hyperalgesia and allodynia require activation of both Cav3.2 and TRPA1 channels in mice. Br J Pharmacol, 2012; 166: 1738-43
58. Distrutti E, Cipriani S, Renga B et al: Hydrogen sulphide induces micro opioid receptor-dependent analgesia in a rodent model of visceral pain. Mol Pain, 2010; 6: 36
59. Miyamoto T, Dubin AE, Petrus MJ, Patapoutian A: TRPV1 and TRPA1 mediate peripheral nitric oxide-induced nociception in mice. PLoS One, 2009; 4: e7596
60. Hervera A, Negrete R, Leánez S et al: Peripheral effects of morphine and expression of μ-opioid receptors in the dorsal root ganglia during neuropathic pain: nitric oxide signaling. Mol Pain, 2011; 7: 25
61. Freire MA, Guimarães JS, Leal WG, Pereira A: Pain modulation by nitric oxide in the spinal cord. Front Neurosci, 2009; 3: 175-81
62. Bijjem KR, Padi SS, lal Sharma P: Pharmacological activation of heme oxygenase (HO)-1/carbon monoxide pathway prevents the development of peripheral neuropathic pain in Wistar rats. Naunyn Schmiedebergs Arch Pharmacol, 2013; 386: 79-90
63. Nascimento CG, Branco LG: Antinociception synergy between the peripheral and spinal sites of the heme oxygenase-carbon monoxide pathway. Braz J Med Biol Res, 2009; 42: 141-47
64. Hervera A, Gou G, Leánez S, Pol O: Effects of treatment with a carbon monoxide-releasing molecule and a heme oxygenase 1 inducer in the antinociceptive effects of morphine in different models of acute and chronic pain in mice. Psychopharmacology (Berl), 2013; 228: 463-77
65. Andrade P, Visser-Vandewalle V, Hoffmann C et al: Role of TNF-alpha during central sensitization in preclinical studies. Neurol Sci, 2011; 32: 757-71
66. Park CK, Lü N, Xu ZZ et al: Resolving TRPV1-and TNF-a-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1. J Neurosci, 2011; 31: 15072-85
67. Wang F, Xu S, Shen X et al: Spinal macrophage migration inhibitory factor is a major contributor to rodent neuropathic pain-like hypersensitivity. Anesthesiology, 2011; 114: 643-59
68. Alexander JK, Cox GM, Tian JB et al: Macrophage migration inhibitory factor (MIF) is essential for inflammatory and neuropathic pain and enhances pain in response to stress. Exp Neurol, 2012; 236: 351-62
69. Sun Y, Wang Y, Li JH et al: Macrophage migration inhibitory factor counter-regulates dexamethasone-induced Annexin 1 expression and influences the release of eicosanoids in murine macrophages. Immunology, 2013; 140: 250-58
70. Koh IJ, Chang CB, Lee JH et al: Preemptive Low-dose Dexamethasone Reduces Postoperative Emesis and Pain After TKA: A Randomized Controlled Study. Clin Orthop Relat Res, 2013; 471: 3010-20
71. de Oliveira CM, Sakata RK, Issy AM et al: Cytokines and pain. Rev Bras Anestesiol, 2011; 61: 260-65
72. Ren K, Torres R: Role of interleukin-1beta during pain and inflammation. Brain Res Rev, 2009; 60: 57-64
73. Guo W, Wang H, Watanabe M et al: Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J Neurosci, 2007; 27: 6006-18
74. Leibinger M, Müller A, Gobrecht P et al: Interleukin-6 contributes to CNS axon regeneration upon inflammatory stimulation. Cell Death Dis, 2013; 4: e609
75. Muja N, DeVries GH: Prostaglandin E(2) and 6-keto-prostaglandin F(1alpha) production is elevated following traumatic injury to sciatic nerve. Glia, 2004; 46: 116-29
76. Kunori S, Matsumura S, Okuda-Ashitaka E et al: A novel role of prostaglandin E2 in neuropathic pain: blockade of microglial migration in the spinal cord. Glia, 2011; 59: 208-18
77. Okuda-Ashitaka E, Minami T, Matsumura S et al: The opioid peptide nociceptin/ orphanin FQ mediates prostaglandin E2-induced allodynia, tactile pain associated with nerve injury. Eur J Neurosci, 2006; 23: 995-1004
78. Shen X, Yuan H, Wang W et al: Homeostatic synaptic plasticity: balanced by COX2-PGE2 system to a new setpoint. Sci Insights, 2013; 1: 20-23
79. Dray A, Perkins M: Bradykinin and inflammatory pain. Trends Neurosci, 1993; 16: 99-104
80. Banik RK, Kozaki Y, Sato J et al: B2 receptor-mediated enhanced bradykinin sensitivity of rat cutaneous C-fiber nociceptors during persistent inflammation. J Neurophysiol, 2001; 86: 2727-35
81. Nakamura Y, Izumi H, Shimizu T et al: Volume transmission of substance P in striatum induced by intraplantar formalin injection attenuates nociceptive responses via activation of the neurokinin 1 receptor. J Pharmacol Sci, 2013; 121: 257-71
82. López-Bellido R, Barreto-Valer K, Rodríguez RE: Substance P mRNA expression during zebrafish development: influence of mu opioid receptor and cocaine. Neuroscience, 2013; 242: 53-68
83. Nazarian A, Tenayuca JM, Almasarweh F et al: Sex differences in formalinevoked primary afferent release of substance P. Eur J Pain, 2014; 18: 39-46
84. Wei T, Guo TZ, Li WW et al: Keratinocyte expression of inflammatory mediators plays a crucial role in substance P-induced acute and chronic pain. J Neuroinflammation, 2012; 9: 181
85. Wei T, Li WW, Guo TZ et al: Post-junctional facilitation of Substance P signaling in a tibia fracture rat model of complex regional pain syndrome type I. Pain, 2009; 144: 278-86
86. Kingery WS, Davies MF, Clark JD: A substance P receptor (NK1) antagonist can reverse vascular and nociceptive abnormalities in a rat model of complex regional pain syndrome type II. Pain, 2003; 104: 75-84
87. Kashiba H, Fukui H, Morikawa Y, Senba E: Gene expression of histamine H1 receptor in guinea pig primary sensory neurons: a relationship between H1 receptor mRNA-expressing neurons and peptidergic neurons. Brain Res Mol Brain Res, 1999; 66: 24-34
88. Nuutinen S, Panula P: Histamine in neurotransmission and brain diseases. Adv Exp Med Biol, 2010; 709: 95-107
89. Deval E, Gasull X, Noël J et al: Acid-sensing ion channels (ASICs): pharmacology and implication in pain. Pharmacol Ther, 2010; 128: 549-58
90. Holzer P: Acid sensing by visceral afferent neurones. Acta Physiol (Oxf), 2011; 201: 63-75
91. Hayashi K, Shiozawa S, Ozaki N et al: Repeated intramuscular injections of nerve growth factor induced progressive muscle hyperalgesia, facilitated temporal summation, and expanded pain areas. Pain, 2013; 154: 2344-52
92. Osikowicz M, Longo G, Allard S et al: Inhibition of endogenous NGF degradation induces mechanical allodynia and thermal hyperalgesia in rats. Mol Pain, 2013; 9: 37
93. Shaqura M, Khalefa BI, Shakibaei M et al: Reduced number, G protein coupling, and antinociceptive efficacy of spinal mu-opioid receptors in diabetic rats are reversed by nerve growth factor. J Pain, 2013; 14: 720-30
94. Webber CA, Salame J, Luu GL et al: Nerve growth factor acts through the TrkA receptor to protect sensory neurons from the damaging effects of the HIV-1 viral protein, Vpr. Neuroscience, 2013; 252: 512-25
95. Kobayashi K, Yamanaka H, Yanamoto F et al: Multiple P2Y subtypes in spinal microglia are involved in neuropathic pain after peripheral nerve injury. Glia, 2012; 60: 1529-39
96. Mo G, Grant R, O'Donnell D et al: Neuropathic Nav1.3-mediated sensitization to P2X activation is regulated by protein kinase C. Mol Pain, 2011; 7: 14
97. Kanno T, Yaguchi T, Nishizaki T: Noradrenaline stimulates ATP release from DRG neurons by targeting beta(3) adrenoceptors as a factor of neuropathic pain. J Cell Physiol, 2010; 224: 345-51
98. Burnstock G, Krügel U, Abbracchio MP, Illes P: Purinergic signalling: from normal behaviour to pathological brain function. Prog Neurobiol, 2011; 95: 229-74